Overview

Propofol Cardioprotection for Type II Diabetics

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if an intravenous anesthetic with antioxidant properties will protect the heart of diabetic patients from injury while undergoing coronary bypass surgery.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of British Columbia

Collaborator:

Canadian Institutes of Health Research (CIHR)

Treatments:

Propofol